Big pharma: Prescription sales and growth trends of the world’s top 20 drugmakers
By APFriday, August 7, 2009
Ranking Rx: Top 20 drugmakers by annual sales
Rankings of the world’s Top 20 drugmakers, based on global prescription drug sales for the year ending in March 2009, when total pharmaceutical industry revenue grew about 5 percent to more than $720 billion. Figures do not include revenue of company units selling consumer and animal health products, medical devices or diagnostic products.
| Rank/Company | Drug | Revenue | Market | Share | Growth | Rate | 2004-08 | Growth |
| 1. Pfizer | $42.4 | billion | 5.9 | percent | -3.3 | percent | -2.7 | percent |
| 2. Novartis | $36.2 | billion | 5.0 | percent | 3.5 | percent | 7.5 | percent |
| 3. Sanofi-Aventis | $35.6 | billion | 4.9 | percent | 3.7 | percent | 4.6 | percent |
| 4. GlaxoSmithKline | $35.0 | billion | 4.8 | percent | -6.5 | percent | 2.9 | percent |
| 5. AstraZeneca | $32.6 | billion | 4.5 | percent | 6.5 | percent | 9.3 | percent |
| 6. Roche | $30.3 | billion | 4.2 | percent | 6.8 | percent | 15.3 | percent |
| 7. Johnson & Johnson | $28.7 | billion | 4.0 | percent | -1.8 | percent | 3.0 | percent |
| 8. Merck | $25.3 | billion | 3.5 | percent | -8.3 | percent | 3.3 | percent |
| 9. Abbott | $19.3 | billion | 2.7 | percent | 9.2 | percent | 9.1 | percent |
| 10. Eli Lilly | $19.2 | billion | 2.7 | percent | 8.8 | percent | 9.3 | percent |
| 11. Bayer | $15.7 | billion | 2.2 | percent | 6.2 | percent | 6.4 | percent |
| 12. Teva | $15.3 | billion | 2.1 | percent | 14.6 | percent | 14.4 | percent |
| 13. Wyeth | $15.3 | billion | 2.1 | percent | -2.8 | percent | 4.4 | percent |
| 14. Amgen | $15.0 | billion | 2.1 | percent | -4.0 | percent | 14.3 | percent |
| 15. Bristol-Myers Squibb | $14.2 | billion | 2.0 | percent | 6.1 | percent | -4.7 | percent |
| 16. Boehringer Ingelheim | $14.2 | billion | 2.0 | percent | 9.1 | percent | 13.5 | percent |
| 17. Takeda | $14.0 | billion | 1.9 | percent | 2.7 | percent | 6.7 | percent |
| 18. Schering-Plough | $13.3 | billion | 1.8 | percent | 5.3 | percent | 2.0 | percent |
| 19. Daiichi Sankyo | $8.3 | billion | 1.1 | percent | 4.0 | percent | 4.2 | percent |
| 20. Novo Nordisk | $8.0 | billion | 1.1 | percent | 12.9 | percent | 15.6 | percent |
| —————————————————————————————————————————————————————————————————————————————————————— | ||||||||
| Top 20 total | $438 | billion | 60.7 | percent | 2.1 | percent | 5.3 | percent |
____
Source: Health data firm IMS Health.
YOUR VIEW POINT
